Humira and biosimilars — CareFirst (Caremark)

Initial criteria

• Member previously received Otezla or biologic indicated for Behcet’s disease OR inadequate response to at least one non-biologic medication (azathioprine, colchicine, cyclosporine, systemic corticosteroids)

Approval duration

12 months